Brain metabolomics in rats after administration of ketamine

Biomedical Chromatography

Volumn 30, Issue 1, 2016, Pages 81-84

  Wen, Congcong ^a   Zhang, Meiling ^a   Zhang, Yuan ^a   Sun, Fa ^a   Ma, Jianshe ^a   Hu, Lufeng ^b   Lin, Guanyang ^b   Wang, Xianqin ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Abuse; GC MS; Ketamine; Metabolomics

Indexed keywords

AMINES; GAS CHROMATOGRAPHY; LEAST SQUARES APPROXIMATIONS; MASS SPECTROMETRY; PATTERN RECOGNITION; PRINCIPAL COMPONENT ANALYSIS; RATS; UREA;

ABUSE; CONTROL GROUPS; DISCRIMINATE ANALYSIS; GASCHROMATOGRAPHY-MASS SPECTROMETRY; KETAMINE; METABOLOMICS; PARTIAL LEAST-SQUARES; PRINCIPAL-COMPONENT ANALYSIS; RATS BRAIN;

METABOLISM;

CHOLESTEROL; GLYCEROL; KETAMINE; UREA; URIDINE; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; KETAMINE ABUSE; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; NONHUMAN; RAT; ANIMAL; BRAIN; EVALUATION STUDY; METABOLISM; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; BIOMARKERS; BRAIN; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; KETAMINE; MALE; METABOLOMICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84952637952     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3518     Document Type: Article

References (21)

1. Dinis-Oliveira RJ. Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity. Bioanalysis 2014; 6: 3155-3159.
2. Domino EF, Chodoff P and Corssen G. Pharmacologic effects of Ci-581, a new dissociative anesthetic, in man. Clinical Pharmacological Therapy 1965; 6: 279-291.
3. Fendrich M, Wislar JS, Johnson TP and Hubbell A. A contextual profile of club drug use among adults in Chicago. Addiction 2003; 98: 1693-1703.
4. Gu D, Huang J, Shan Z, Yin Y, Zheng S and Wu P. Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system. International Journal of Urology 2013; 20: 1024-1031.
5. Gu D, Huang J, Yin Y, Shan Z, Zheng S and Wu P. Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier. Molecular Biology Reports 2014; 41: 7313-7322.
6. Harris SR, Zhang GF, Sadhukhan S, Wang H, Shi C, Puchowicz MA, Anderson VE, Salomon RG, Tochtrop GP and Brunengraber H. Metabolomics and mass isotopomer analysis as a strategy for pathway discovery: pyrrolyl and cyclopentenyl derivatives of the pro-drug of abuse, levulinate. Chemical Research and Toxicology 2013; 26: 213-220.
7. Harrison NL and Simmonds MA. Quantitative studies on some antagonists of N-methyl d-aspartate in slices of rat cerebral cortex. British Journal of Pharmacology 1985; 84: 381-391.
8. Hiller K, Hangebrauk J, Jager C, Spura J, Schreiber K and Schomburg D. MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis. Analytical Chemistry 2009; 81: 3429-3439.
9. Kaddurah-Daouk R, Kristal BS and Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annual Reviews in Pharmacology and Toxicology 2008; 48: 653-83.
10. Kenyon SL, Ramsey JD, Lee T, Johnston A and Holt DW. Analysis for identification in amnesty bin samples from dance venues. Therapeutic Drug Monitoring 2005; 27: 793-798.
11. Kiss A, Lucio M, Fildier A, Buisson C, Schmitt-Kopplin P and Cren-Olive C. Doping control using high and ultra-high resolution mass spectrometry based non-targeted metabolomics - a case study of salbutamol and budesonide abuse. PLoS One 2013; 8: e74584.
12. Lenton S, Boys A and Norcross K. Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia. Addiction 1997; 92: 1327-1337.
13. Leong HS, Tan NL, Lui CP and Lee TK. Evaluation of ketamine abuse using hair analysis: concentration trends in a Singapore population. Journal of Analytical Toxicology 2005; 29: 314-318.
14. Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJ and Curran HV. Journey through the K-hole: phenomenological aspects of ketamine use. Drug and Alcohol Dependency 2008; 95: 219-229.
15. Tsugawa H, Tsujimoto Y, Arita M, Bamba T and Fukusaki E. GC/MS based metabolomics: development of a data mining system for metabolite identification by using soft independent modeling of class analogy (SIMCA). BMC Bioinformatics 2011; 12: 131.
16. Turfus SC, Parkin MC, Cowan DA, Halket JM, Smith NW, Braithwaite RA, Elliot SP, Steventon GB and Kicman AT. Use of human microsomes and deuterated substrates: an alternative approach for the identification of novel metabolites of ketamine by mass spectrometry. Drug Metabolism and Disposition 2009; 37: 1769-1778.
17. van Velzen M and Dahan A. Ketamine metabolomics in the treatment of major depression. Anesthesiology 2014; 121: 4-5.
18. Villasenor A, Ramamoorthy A, Silva dos Santos M, Lorenzo MP, Laje G, Zarate C Jr, Barbas C and Wainer IW. A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks. British Journal of Pharmacology 2014; 171: 2230-2242.
19. Wang X, Zhang M, Ma J, Zhang Y, Hong G, Sun F, Lin G and Hu L. Metabolic changes in paraquat poisoned patients and support vector machine model of discrimination. Biological and Pharmaceutical Bulletin 2015; 38: 470-475.
20. White PF, Way WL and Trevor AJ. Ketamine - its pharmacology and therapeutic uses. Anesthesiology 1982; 56: 119-136.
21. Zhang M, Deng M, Ma J and Wang X. An evaluation of acute hydrogen sulfide poisoning in rats through serum metabolomics based on gas chromatography-mass spectrometry. Chemical and Pharmacy Bulletin (Tokyo) 2014; 62: 505-507.